Stem Cells Translational Medicine

SJR Rank #2,194H-index: 116SJR: 1.588Best quartile: Q1Open AccessAPC: US$2,963Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Oxford University Press

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.40.81.21.6

Subject Categories

  • Developmental BiologyQ1
  • Medicine (miscellaneous)Q1
  • Cell BiologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Mesenchymal stem cell researchPluripotent Stem Cells ResearchTissue Engineering and Regenerative MedicineBiomedical Ethics and RegulationCRISPR and Genetic EngineeringNeurogenesis and neuroplasticity mechanismsHematopoietic Stem Cell TransplantationExtracellular vesicles in diseaseNeonatal Respiratory Health ResearchCancer Cells and Metastasis

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs070140210280

Documents per Year

202220250306090120

Detailed Information

ISSN

2157-6564, 2157-6580

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

6.03

References per Document

55.30

Coverage

2012-2026

Scope

STEM CELLS Translational Medicine is a monthly, peer-reviewed, largely online, open access journal. STEM CELLS Translational Medicine works to advance the utilization of cells for clinical therapy. By bridging stem cell molecular and biological research and helping speed translations of emerging lab discoveries into clinical trials, STEM CELLS Translational Medicine will help move applications of these critical investigations closer to accepted best patient practices and ultimately improve outcomes. The journal encourages original research articles and concise reviews describing laboratory investigations of stem cells, including their characterization and manipulation, and the translation of their clinical aspects of from the bench to patient care. STEM CELLS Translational Medicine covers all aspects of translational cell studies, including bench research, first-in-human case studies, and relevant clinical trials.

Metrics from SCImago Journal Rank 2025. View on SCImago